These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7940831)

  • 1. Malignancy under immunosuppressive therapy including cyclosporine.
    Ritters B; Grabensee B; Heering P
    Transplant Proc; 1994 Oct; 26(5):2656-7. PubMed ID: 7940831
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine therapy in pancreas transplantation.
    Davidson I; Lu C; Melone D; Risser R
    Transplant Proc; 1996 Aug; 28(4):2134-5. PubMed ID: 8769179
    [No Abstract]   [Full Text] [Related]  

  • 3. Increasing transplant cancer patient survival by conversion of immunosuppressive agents.
    Chuang FR; Hsieh H; Hsu KT; Huang HF
    Transplant Proc; 1996 Jun; 28(3):1346-7. PubMed ID: 8658687
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence and type of malignancies occurring after renal transplantation in conventionally and cyclosporine-treated recipients: analysis of a 20-year period in 1600 patients.
    Hiesse C; Kriaa F; Rieu P; Larue JR; Benoit G; Bellamy J; Blanchet P; Charpentier B
    Transplant Proc; 1995 Feb; 27(1):972-4. PubMed ID: 7879250
    [No Abstract]   [Full Text] [Related]  

  • 5. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumors after transplantation: are there associated factors?
    Jacobs U; Paar D; Buszello H; Klehr HU
    Transplant Proc; 1996 Dec; 28(6):3248. PubMed ID: 8962258
    [No Abstract]   [Full Text] [Related]  

  • 7. One thousand renal transplants at Belfast City Hospital: post-graft neoplasia 1968-1999, comparing azathioprine only with cyclosporin-based regimes in a single centre.
    McGeown MG; Douglas JF; Middleton D
    Clin Transpl; 2000; ():193-202. PubMed ID: 11512313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney transplantation in pediatric population.
    Mota C; Henriques C; Sarmento M; Pereira E; Xavier E; Pereira M
    Transplant Proc; 1994 Oct; 26(5):2768-70. PubMed ID: 7940872
    [No Abstract]   [Full Text] [Related]  

  • 9. Dilemma: maintenance therapy enhances sclerogenic risk profile.
    Jacobs U; Klein B; Miersch WD; Molitor D; Klehr HU
    Transplant Proc; 1996 Dec; 28(6):3227-30. PubMed ID: 8962249
    [No Abstract]   [Full Text] [Related]  

  • 10. Toward optimal induction with cyclosporine therapy.
    Pfaff WW; Howard RJ; Patton PR; Peterson JC; Fennell RS; Karlix JL; Reed AI; Rosen CB; Scornik JC
    Transplant Proc; 1996 Aug; 28(4):2109-10. PubMed ID: 8769169
    [No Abstract]   [Full Text] [Related]  

  • 11. Donor-specific transfusion for kidney transplantation in the cyclosporine era.
    Inoue S; Aikawa M; Dobashi Y; Kuzuhara K; Yanagisawa T; Ootubo O; Mimura N
    Transplant Proc; 1996 Jun; 28(3):1220-1. PubMed ID: 8658633
    [No Abstract]   [Full Text] [Related]  

  • 12. Malignancies under cyclosporine after kidney transplantation: analysis of a 10-year period.
    Frei U; Bode U; Repp H; Schindler R; Brunkhorst R; Vogt P; Hauss J; Pichlmayr R
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1394-6. PubMed ID: 8442152
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunosuppression in live-related donor renal transplantation.
    Iman A; Rao M; Juneja R; Jacob CK
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin monotherapy in pancreaticorenal transplantation.
    Ward RG; Gecim E; Bone JM; Bakran A; Sells RA
    Transplant Proc; 1994 Apr; 26(2):548. PubMed ID: 8171547
    [No Abstract]   [Full Text] [Related]  

  • 15. Cadaveric renal transplantation with cyclosporine monotherapy.
    Aikawa A; Sells RA; Bakran A; Tewari A
    Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors for malignancy in Japanese renal transplant recipients.
    Imao T; Ichimaru N; Takahara S; Kokado Y; Okumi M; Imamura R; Namba Y; Isaka Y; Nonomura N; Okuyama A
    Cancer; 2007 May; 109(10):2109-15. PubMed ID: 17407138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of antilymphocyte globulin upon the incidence of malignancies after kidney transplantation.
    Luciani J; Benalia H; Bitker MO; Mouquet C; Chartier-Kastler E; Ourhama S; Jacobs C; Chatelain C; Viars P
    Transplant Proc; 1993 Jun; 25(3):2302. PubMed ID: 8516907
    [No Abstract]   [Full Text] [Related]  

  • 19. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation.
    Bakr MA; Sally S; Foda MA; Sobh MA; el-Sherif AK; Ghoneim MA
    Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
    Joss N; Rodger RS; McMillan MA; Junor BJ
    Transplantation; 2007 Mar; 83(5):582-7. PubMed ID: 17353778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.